Date Initiated by Firm | September 26, 2024 |
Date Posted | October 30, 2024 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-0262-2025 |
Recall Event ID |
95466 |
510(K)Number | K152481 |
Product Classification |
Dura substitute - Product Code GXQ
|
Product | Duraform Dural Graft Implant, Size 3x3 , Model Number 80-1477US
Lot CT007694 |
Code Information |
Part# 80-1477US
Lot# CT007694
UDI# 10886704079477 |
Recalling Firm/ Manufacturer |
Integra LifeSciences Corp. 1100 Campus Rd Princeton NJ 08540-6650
|
For Additional Information Contact | Lacey Gigante 1-609-212-9004 |
Manufacturer Reason for Recall | Out of specification endotoxin levels. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | An URGENT - FIELD SAFETY NOTICE dated 9/26/24 was sent to the customer.
Actions to be Taken by Distributors:
1. If you do have the affected product listed in Table 1, remove the product from further
distribution and place them in quarantine.
2. If you do have affected product, check the box on the enclosed form I do have affected product.
3. If you do not have affected product, check the box, I do not have affected product.
4. Complete the attached Distributor Reply Form in Appendix 1 and return to
FCA1@integralife.com or electronic FAX to 1-609-750-4220.
5. Keep a copy of the form for your records.
6. Please manage the returns with your customers per your process : credit can be
provided if your customers have any product to return and they return it to you.
7. Forward a copy of the enclosed Field Safety Notice to any of your customers that have
purchased the affected product. If you need a copy of a Customer Reply Form , use the
one in Appendix 2, as applicable.
PLEASE NOTE THAT REGARDLESS OF WHETHER YOU HAVE THE AFFECTED PRODUCT OR
NOT A COMPLETED ACKNOWLEDGEMENT IS REQUIRED
Finally, if required by the national medical device regulation of your distribution area, please ensure this Field Safety Corrective Action is notified to the national competent authorities.
Thank you for your cooperation with this Field Safety Corrective Action and for returning the attached Reply Form. See return instructions on top of the reply forms in Appendix 1.
Please feel free to contact our Post Market Surveillance Department at FCA1@integralife.com for any additional questions. |
Quantity in Commerce | 128 units |
Distribution | China |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database | 510(K)s with Product Code = GXQ
|